Maplelane Capital’s Illumina ILMN Stock Holding History

Maplelane Capital’s Portfolio ILMN Stock Details ILMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-190,180	Closed	-$34.3M	–	172
2015 Q1	$34.3M	Buy	190,180 +107,940	+131%	+$20.3M	1.13%	30
2014 Q4	$14.8M	Buy	+82,240	New	+$14.5M	0.55%	53
2014 Q2	–	Sell	-267,280	Closed	-$38.7M	–	142
2014 Q1	$38.7M	Buy	+267,280	New	+$39.3M	1.29%	20

Other funds holding ILMN

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Maplelane Capital's ILMN Position: Q2 2015 in Review

Maplelane Capital sold out of Illumina (ILMN) in Q2 2015, closing a stake of 41,121 shares — an estimated $7.43M sold.

Maplelane Capital first reported a position in ILMN in Q1 2014 and held it in 3 quarters. The position peaked at $7.75M in Q4 2014. 569 funds tracked by Wall St. Rank hold ILMN as of Q2 2015.

Maplelane Capital reported no remaining Illumina position as of Q2 2015 after selling out during the quarter.
Maplelane Capital sold 41,121 Illumina shares in Q2 2015, an estimated $7.43M.
Maplelane Capital first reported a position in Illumina in Q1 2014 and held it in 3 quarters.
Maplelane Capital's Illumina position peaked at $7.75M in Q4 2014.
569 funds tracked by Wall St. Rank held Illumina as of Q2 2015.

Based on Maplelane Capital's 13F filing for Q2 2015, filed 14 Aug 2015.